3. June 2025 • News
Leipzig University’s first Cluster of Excellence is receiving multi-year government funding to research common metabolic disorders.
The Excellence Commission of the German federal and state governments has designated Leipzig University’s research cluster on metabolic disorders as a ‘Cluster of Excellence’ – a first for the university. The German Research Foundation (DFG) and the German Council of Science and Humanities (WR) announced that beginning in 2026, the Leipzig Center of Metabolism (LeiCeM) will be receiving multi-million-euro funding over the coming years. The Cluster is a collaborative effort between the University of Leipzig Medical Center, the Leipzig Heart Center, the Leipzig-based Helmholtz Institute for Metabolic, Obesity, and Vascular Research (HI-MAG), as well as Max Planck and Fraunhofer Institutes.
Great excitement after the announcement of the excellence decision: from left to right, Prorektor Prof. Dr. Jens-Karl Eilers, LeiCeM-Co-Sprecherin Prof. Dr. Antje Körner, LeiCeM-Sprecher Prof. Dr. Michael Stumvoll und Rektorin Prof. Dr. Eva Inés Obergfell. credit: Christian Hüller/Universität Leipzig
The scientists in Leipzig are already conducting world-class clinical research on understanding and improving the burden of disease caused by metabolic disorders. They will now be able to intensify their studies into conditions like obesity, diabetes, and fatty liver disease. These common illnesses are often associated with serious secondary diseases such as heart attacks, strokes, organ failure, and neurodegenerative disorders. The researchers will also be taking a closer look at the individual causes of disease such as genetic predispositions, early childhood influences, sex-specific differences, and mental health. One goal is to develop more targeted diagnostics and personalised treatment plans to improve patient outcomes.
Find out more at uni-leipzig.de
University Hospital Leipzig partnered with Apple to hold its first workshop on spatial computing for neurosurgeons in November 2024. The course offered insights into and hands-on practice with this latest technology.
cell-immune-gene-therapies
Small glas bottle which is normally used to store vaccine
Chimeric Antigen Receptor T Cell Therapy (CAR-T): Genetically programmed immune cell binds to and destroys cancer cell / Therapy is now available for the majority of indications
digital-health
Human who looks onto a recording of brainwaves on his tablet computer and moves the model with his fingers
The Smart Infrastructure Hub Leipzig will receive a further 1,9 million euros from the cluster funding of the Saxon Ministry of Economic Affairs.
cell-immune-gene-therapies
Small glas bottle which is normally used to store vaccine
A relatively small metropolis in Germany’s Free State of Saxony – a dynamic hub for the life science industry? What was just a vision 20 years ago has become a reality for the city of Leipzig, which from October 24-26 co-hosted BIO-Europe, Europe’s largest annual biotech partnering event.
